The first FDA-approved injectable for cellulite is here, but it's not always a quick fix, according to Allure.
Under the terms of the agreement, Sanmina Corporation will manufacture Soliton’s RAP device and replaceable cartridges, Soliton announces.Read More
The US Food and Drug Administration (FDA) has cleared a new indication statement that shows the benefits of the Cellfina System lasts for 5 years, an increase from the previous 3-year indication, Merz announces.Read More
Soliton Inc announces it will move forward with a pivotal cellulite trial after results from its Proof of Concept (POC) clinical trial revealed a 20% to 47% improvement in the cellulite severity score.Read More
With a 94% patient-satisfaction rating at 1 year, Cellfina just may be the must-have cellulite treatment for summer 2015.Read More